OklahomaNon-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Apr 1Second Reading referred to Health and Human Services Committee then to Appropriations CommitteeLatest
- Mar 4First ReadingMinor
- Mar 4Engrossed, signed, to SenatePassed Senate
- Mar 3Referred for engrossment
- Vote recorded Third Reading. Result: pass.Lower
- Mar 3Third Reading, Measure passed: Ayes: 90 Nays: 7Passed House
- Mar 3Title stricken
- Mar 3AmendedMajor
- Mar 3Coauthored by Representative(s) Fugate
- Mar 3General Order
- Feb 26CR; Do Pass, amended by committee substitute Health and Human Services Oversight CommitteeMinor
- Vote recorded Health And Human Services Oversight Committee: Do Pass As Amended By Cs. Result: pass.Lower
- Feb 5Authored by Senator Rosino (principal Senate author)
- Vote recorded Public Health Committee: Do Pass. Result: pass.Lower
- Feb 5Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public HealthMinor
- Feb 4Referred to Public HealthMinor
- Feb 4Second Reading referred to Health and Human Services OversightMinor
- Feb 3Authored by Representative West (Josh)
- Feb 3First ReadingIntroduced